Page last updated: 2024-09-04

allotrap and Neoplasm Metastasis

allotrap has been researched along with Neoplasm Metastasis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belmar, N; Buelow, R; Fong, T; Huang, L; Zhao, J1

Other Studies

1 other study(ies) available for allotrap and Neoplasm Metastasis

ArticleYear
Oral RDP58 allows CPT-11 dose intensification for enhanced tumor response by decreasing gastrointestinal toxicity.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Apr-15, Volume: 10, Issue:8

    Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Line, Tumor; Cytokines; Digestive System; Dose-Response Relationship, Drug; Female; Fluorouracil; Histocompatibility Antigens Class I; Intestinal Mucosa; Irinotecan; Jejunum; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Peptides; Time Factors

2004